The epidemiology of early inflammatory arthritis

Nature Reviews Rheumatology

Volumn 7, Issue 7, 2011, Pages 381-390

  Hazes, Johanna M W ^a   Luime, Jolanda J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC CITRULLINATED PEPTIDE ANTIBODY; DISEASE MODIFYING ANTIRHEUMATIC DRUG; EPITOPE; GLUCOCORTICOID; HLA DQ ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 10; METHOTREXATE; PLACEBO; RHEUMATOID FACTOR;

AREA UNDER THE CURVE; ARTHRALGIA; ARTHRITIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; DISEASE COURSE; DRUG DOSE REDUCTION; EARLY DIAGNOSIS; EARLY INFLAMMATORY ARTHRITIS; EARLY INTERVENTION; ENVIRONMENTAL FACTOR; EPIDEMIOLOGICAL DATA; ERYTHROCYTE SEDIMENTATION RATE; GENOTYPE; HAPLOTYPE; HEREDITY; HOMOZYGOSITY; HUMAN; IMMUNOPATHOGENESIS; INCIDENCE; INFLAMMATORY ARTHRITIS; INFLAMMATORY DISEASE; JOINT STIFFNESS; METATARSOPHALANGEAL JOINT; POPULATION RESEARCH; PREDICTION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SYMPTOMATOLOGY; TREATMENT DURATION; UNDIFFERENTIATED ARTHRITIS;

ARTHRITIS; ARTHRITIS, RHEUMATOID; DISEASE PROGRESSION; EARLY DIAGNOSIS; FEMALE; HUMANS; MALE; RISK FACTORS; SYNOVITIS; WORLD HEALTH;

EID: 79960004355     PISSN: 17594790     EISSN: 17594804     Source Type: Journal    
DOI: 10.1038/nrrheum.2011.78     Document Type: Review

References (73)

1. Klareskog, L., Nordmark, B. & Lindblad, S. On the organization of an early arthritis clinic. Best Pract. Res. Clin. Rheumatol. 15, 1-15 (2001). (Pubitemid 32396427)
2. Bykerk, V. P. & Hazes, J. M. When does rheumatoid arthritis start and can it be stopped before it does? Ann. Rheum. Dis. 69, 473-475 (2010).
3. Banal, F., Dougados, M., Combescure, C. & Gossec, L. Sensitivity and specificity of the American College of Rheumatology 1987 criteria for the diagnosis of rheumatoid arthritis according to disease duration: a systematic literature review and meta-analysis. Ann. Rheum. Dis. 68, 1184-1191 (2009).
4. Berthelot, J. M., Saraux, A., Maugars, Y., Prost, A. & Le Goff, P. The nosology-taxonomy of recent-onset arthritis: the experience of early-arthritis clinics. Semin. Arthritis Rheum. 30, 354-365 (2001). (Pubitemid 32298861)
5. Funovits, J. et al. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: methodological report phase I. Ann. Rheum. Dis. 69, 1589-1595 (2010).
6. Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62, 2569-2581 (2010).
7. Neogi, T. et al. The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: phase 2 methodological report. Arthritis Rheum. 62, 2582-2591 (2010).
8. Arnett, F. C. et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31, 315-324 (1988). (Pubitemid 18091653)
9. Nielen, M. M. et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 50, 380-386 (2004). (Pubitemid 38198821)
10. McInnes, I. B. & Schett, G. Cytokines in the pathogenesis of rheumatoid arthritis. Nat. Rev. Immunol. 7, 429-442 (2007). (Pubitemid 46834849)
11. Scott, D. L., Wolfe, F. & Huizinga, T. W. Rheumatoid arthritis. Lancet 376, 1094-1108 (2010).
12. van Baarsen, L. G. et al. Gene expression profiling in autoantibody-positive patients with arthralgia predicts development of arthritis. Arthritis Rheum. 62, 694-704 (2010).
13. Klareskog, L., Malmstrom, V., Lundberg, K., Padyukov, L. & Alfredsson, L. Smoking, citrullination and genetic variability in the immunopathogenesis of rheumatoid arthritis. Semin. Immunol. 23, 92-98 (2011).
14. Visser, H., le Cessie, S., Vos, K., Breedveld, F. C. & Hazes, J. M. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum. 46, 357-365 (2002). (Pubitemid 34136572)
15. Visser, H. & Hazes, J. M. The diagnosis and prognosis of early arthritis: comment on the editorial by Scott. Arthritis Rheum. 48, 856-857 (2003). (Pubitemid 36302027)
16. Stockman, A. et al. Clinical, laboratory and genetic markers associated with erosions and remission in patients with early inflammatory arthritis: a prospective cohort study. Rheumatol. Int. 26, 500-509 (2006).
17. Harrison, B. & Symmons, D. Early inflammatory polyarthritis: results from the Norfolk Arthritis Register with a review of the literature. II. Outcome at three years. Rheumatology (Oxford) 39, 939-949 (2000).
18. van Aken, J., van Bilsen, J. H., Allaart, C. F., Huizinga, T. W. & Breedveld, F. C. The Leiden Early Arthritis Clinic. Clin. Exp. Rheumatol. 21, S100-S105 (2003). (Pubitemid 37265597)
19. Machold, K. P. et al. The Austrian Early Arthritis Registry. Clin. Exp. Rheumatol. 21, S113-S117 (2003). (Pubitemid 37265599)
20. Jansen, L. M., van Schaardenburg, D., van der Horst-Bruinsma, I. E. & Dijkmans, B. A. One year outcome of undifferentiated polyarthritis. Ann. Rheum. Dis. 61, 700-703 (2002). (Pubitemid 34787707)
21. Quinn, M. A. et al. Prognostic factors in a large cohort of patients with early undifferentiated inflammatory arthritis after application of a structured management protocol. Arthritis Rheum. 48, 3039-3045 (2003). (Pubitemid 37409313)
22. Combe, B. et al. The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients. Joint Bone Spine 74, 440-445 (2007). (Pubitemid 47588984)
23. Reneses, S. et al. A recent onset inflammatory polyarthritis register in Spain: factors that predict remission. Scand. J. Rheumatol. 36, 378-385 (2007). (Pubitemid 350034812)
24. Mjaavatten, M. D. et al. Pattern of joint involvement and other disease characteristics in 634 patients with arthritis of less than 16 weeks' duration. J. Rheumatol. 36, 1401-1406 (2009).
25. Dobkin, P. L. et al. Identifying target areas of treatment for depressed early inflammatory arthritis patients. Psychother Psychosom 77, 298-305 (2008).
26. Saraux, A. et al. Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum. 44, 2485-2491 (2001). (Pubitemid 33049326)
27. Marcos, J. et al. General characteristics of an early arthritis cohort in Argentina. Rheumatology (Oxford) 50, 110-116 (2011).
28. Combe, B. et al. EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT).Ann. Rheum. Dis. 66, 34-45 (2007). (Pubitemid 46044858)
29. Nell, V. P. et al. Benefit of very early referral and very early therapy with disease-modifying anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford) 43, 906-914 (2004). (Pubitemid 38996967)
30. Mottonen, T. et al. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum. 46, 894-898 (2002). (Pubitemid 34303799)
31. Anderson, J. J., Wells, G., Verhoeven, A. C. & Felson, D. T. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration. Arthritis Rheum. 43, 22-29 (2000). (Pubitemid 30368209)
32. Lard, L. R., Huizinga, T. W., Hazes, J. M. & Vliet Vlieland, T. P. Delayed referral of female patients with rheumatoid arthritis. J. Rheumatol. 28, 2190-2192 (2001). (Pubitemid 32947860)
33. Bukhari, M. A. et al. Influence of disease-modifying therapy on radiographic outcome in inflammatory polyarthritis at five years: results from a large observational inception study. Arthritis Rheum. 48, 46-53 (2003). (Pubitemid 36091646)
34. Puolakka, K. et al. Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study. Ann. Rheum. Dis. 64, 130-133 (2005). (Pubitemid 40075290)
35. Finckh, A., Liang, M. H., van Herckenrode, C. M. & de Pablo, P. Long-term impact of early treatment on radiographic progression in rheumatoid arthritis: A meta-analysis. Arthritis Rheum. 55, 864-872 (2006). (Pubitemid 44917458)
36. Savolainen, E., Kaipiainen-Seppanen, O., Kroger, L. & Luosujarvi, R. Total incidence and distribution of inflammatory joint diseases in a defined population: results from the Kuopio 2000 arthritis survey. J. Rheumatol. 30, 2460-2468 (2003). (Pubitemid 37413909)
37. Soderlin, M. K., Borjesson, O., Kautiainen, H., Skogh, T. & Leirisalo-Repo, M. Annual incidence of inflammatory joint diseases in a population based study in southern Sweden. Ann. Rheum. Dis. 61, 911-915 (2002).
38. Carbonell, J. et al. The incidence of rheumatoid arthritis in Spain: results from a nationwide primary care registry. Rheumatology (Oxford) 47, 1088-1092 (2008). (Pubitemid 351865940)
39. Emery, P. et al. Early referral recommendation for newly diagnosed rheumatoid arthritis: evidence based development of a clinical guide. Ann. Rheum. Dis. 61, 290-297 (2002). (Pubitemid 34257737)
40. Shapira, Y., Agmon-Levin, N. & Shoenfeld, Y. Geoepidemiology of autoimmune rheumatic diseases. Nat. Rev. Rheumatol. 6, 468-476 (2010).
41. Mjaavatten, M. D. et al. Positive anti-citrullinated protein antibody status and small joint arthritis are consistent predictors of chronic disease in patients with very early arthritis: results from the NOR-VEAC cohort. Arthritis Res. Ther. 11, R146 (2009).
42. Gossec, L. et al. Relative clinical influence of clinical, laboratory, and radiological investigations in early arthritis on the diagnosis of rheumatoid arthritis. Data from the French Early Arthritis Cohort ESPOIR. J. Rheumatol. 37, 2486-2492 (2010).
43. Machold, K. P. et al. Very recent onset arthritis-clinical, laboratory, and radiological findings during the first year of disease. J. Rheumatol. 29, 2278-2287 (2002). (Pubitemid 35266017)
44. de Rooy, D. P., van der Linden, M. P., Knevel, R., Huizinga, T. W. & van der Helm-van Mil, A. H. Predicting arthritis outcomes-what can be learned from the Leiden Early Arthritis Clinic? Rheumatology (Oxford) 50, 93-100 (2011).
45. van Dongen, H. et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum. 56, 1424-1432 (2007). (Pubitemid 46764069)
46. Verstappen, S. M. et al. Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial. Ann. Rheum. Dis. 69, 503-509 (2010).
47. Machold, K. P. et al. The Stop Arthritis Very Early (SAVE) trial, an international multicentre, randomised, double-blind, placebo-controlled trial on glucocorticoids in very early arthritis. Ann. Rheum. Dis. 69, 495-502 (2010).
48. Emery, P. et al. Impact of T-cell costimulation modulation in patients with undifferentiated inflammatory arthritis or very early rheumatoid arthritis: a clinical and imaging study of abatacept (the ADJUST trial).Ann. Rheum. Dis. 69, 510-516 (2010).
49. Bos, W. H. et al. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann. Rheum. Dis. 69, 490-494 (2010).
50. Bell, M. J. et al. Development of a self-administered early inflammatory arthritis detection tool. BMC Musculoskelet. Disord. 11, 50 (2010).
51. Geuskens, G. A., Hazes, J. M., Barendregt, P. J. & Burdorf, A. Work and sick leave among patients with early inflammatory joint conditions. Arthritis Rheum. 59, 1458-1466 (2008).
52. Tunn, E. J. & Bacon, P. A. Differentiating persistent from self-limiting symmetrical synovitis in an early arthritis clinic. Br. J. Rheumatol. 32, 97-103 (1993). (Pubitemid 23077692)
53. Harrison, B. J., Symmons, D. P., Brennan, P., Barrett, E. M. & Silman, A. J. Natural remission in inflammatory polyarthritis: issues of definition and prediction. Br. J. Rheumatol. 35, 1096-1100 (1996).
54. Wolfe, F., Ross, K., Hawley, D. J., Roberts, F. K. & Cathey, M. A. The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1, 141 patients. J. Rheumatol. 20, 2005-2009 (1993). (Pubitemid 24043120)
55. Verstappen, S. M. et al. Disease activity, smoking, and reproductive-related predictors of poor prognosis in patients with very early inflammatory polyarthritis. J. Rheumatol. 38, 429-433 (2011).
56. El Miedany, Y., Youssef, S., Mehanna, A. N. & El Gaafary, M. Development of a scoring system for assessment of outcome of early undifferentiated inflammatory synovitis. Joint Bone Spine 75, 155-162 (2008). (Pubitemid 351418264)
57. van der Linden, M. P. et al. Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum. 62, 3537-3546 (2010).
58. Ursum, J. et al. IL10 GGC haplotype is positively and HLA-DQA1. *05-DQB1. *02 is negatively associated with radiographic progression in undifferentiated arthritis. J. Rheumatol. 37, 1431-1438 (2010).
59. Bukhari, M. et al. Increasing age at symptom onset is associated with worse radiological damage at presentation in patients with early inflammatory polyarthritis. Ann. Rheum. Dis. 66, 389-393 (2007). (Pubitemid 46579642)
60. Jansen, L. M., van der Horst-Bruinsma, I. E., van Schaardenburg, D., Bezemer, P. D. & Dijkmans, B. A. Predictors of radiographic joint damage in patients with early rheumatoid arthritis. Ann. Rheum. Dis. 60, 924-927 (2001). (Pubitemid 32885665)
61. Lard, L. R. et al. Early versus delayed treatment in patients with recent-onset rheumatoid arthritis: comparison of two cohorts who received different treatment strategies. Am. J. Med. 111, 446-451 (2001). (Pubitemid 33016415)
62. Brennan, P. et al. A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study. BMJ 313, 471-476 (1996). (Pubitemid 26280356)
63. Symmons, D. P. & Silman, A. J. Aspects of early arthritis. What determines the evolution of early undifferentiated arthritis and rheumatoid arthritis? An update from the Norfolk Arthritis Register. Arthritis Res. Ther. 8, 214 (2006).
64. van Gaalen, F. A. et al. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis. Arthritis Rheum. 50, 2113-2121 (2004). (Pubitemid 38924388)
65. van der Helm-van Mil, A. H. et al. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum. 56, 433-440 (2007).
66. van der Linden, M. P., Knevel, R., Huizinga, T. W. & van der Helm-van Mil, A. H. Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria. Arthritis Rheum. 63, 37-42 (2011).
67. Alves, C. L. J. J. et al. Diagnostic performance of the ACR/EULAR 2010 criteria for classification of RA and two diagnostic algorithms in an early arthritis clinic (REACH).Ann. Rheum. Dis. (in press).
68. Brown, A. K. et al. An explanation for the apparent dissociation between clinical remission and continued structural deterioration in rheumatoid arthritis. Arthritis Rheum. 58, 2958-2967 (2008).
69. Sugimoto, H., Takeda, A. & Hyodoh, K. Early-stage rheumatoid arthritis: prospective study of the effectiveness of MR imaging for diagnosis. Radiology 216, 569-575 (2000). (Pubitemid 30599883)
70. van der Horst-Bruinsma, I. E., Speyer, I., Visser, H., Breedveld, F. C. & Hazes, J. M. Diagnosis and course of early-onset arthritis: results of a special early arthritis clinic compared to routine patient care. Br. J. Rheumatol. 37, 1084-1088 (1998).
71. Gormley, G. J. et al. Can diagnostic triage by general practitioners or rheumatology nurses improve the positive predictive value of referrals to early arthritis clinics? Rheumatology (Oxford) 42, 763-768 (2003). (Pubitemid 37220908)
72. Kvien, T. K., Glennås, A. & Melby, K. Prediction of diagnosis in acute and subacute oligoarthritis of unknown origin. Br. J. Rheumatol. 35, 359-363 (1996).
73. Nielen, M. M. et al. Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis. Ann. Rheum. Dis. 64, 1199-1204 (2005).